SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-217953
Filing Date
2022-08-11
Accepted
2022-08-11 07:05:41
Documents
14
Period of Report
2022-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d369824d8k.htm   iXBRL 8-K 25831
2 EX-99.1 d369824dex991.htm EX-99.1 96750
6 GRAPHIC g369824g0810221630536.jpg GRAPHIC 3567
  Complete submission text file 0001193125-22-217953.txt   263094

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20220811.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20220811_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20220811_pre.xml EX-101.PRE 11263
8 EXTRACTED XBRL INSTANCE DOCUMENT d369824d8k_htm.xml XML 3368
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 221153632
SIC: 8090 Services-Misc Health & Allied Services, NEC